Does SITAGLIPTIN Cause Product dose omission issue? 1,125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,125 reports of Product dose omission issue have been filed in association with SITAGLIPTIN (JANUVIA). This represents 5.7% of all adverse event reports for SITAGLIPTIN.
1,125
Reports of Product dose omission issue with SITAGLIPTIN
5.7%
of all SITAGLIPTIN reports
1
Deaths
88
Hospitalizations
How Dangerous Is Product dose omission issue From SITAGLIPTIN?
Of the 1,125 reports, 1 (0.1%) resulted in death, 88 (7.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 1,125 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
Death (654)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which SITAGLIPTIN Alternatives Have Lower Product dose omission issue Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE